Johnson & Johnson revealed 22 research collaborations and partnerships on Jan. 7, running the gambit across the company's diversified business and highlighting its emphasis on tapping external sources for innovation.
The deals are ones that culminated in late 2015 and early 2016 that the company chose to highlight ahead of...






![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
